Antibe Therapeutics Inc (ATE.TO)
0.295
0.00 (0.00%)
CAD |
TSX |
May 09, 16:00
Antibe Therapeutics Free Cash Flow (Quarterly): -3.845M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.845M |
| September 30, 2023 | -6.432M |
| Date | Value |
|---|---|
| June 30, 2023 | -4.584M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-6.432M
Minimum
Sep 2023
-3.845M
Maximum
Dec 2023
-4.954M
Average
-4.584M
Median
Jun 2023
Free Cash Flow (Quarterly) Benchmarks
| Biocure Technology Inc | -0.0062M |
| Core One Labs Inc | -- |
| Nova Mentis Life Science Corp | -- |
| Nanosphere Health Sciences Inc | -0.0359M |
| Lobe Sciences Ltd | -0.0948M |